Skip to main content
. 2013 Nov 5;8(2):205–214. doi: 10.5009/gnl.2014.8.2.205

Fig. 3.

Fig. 3

Kaplan-Meier estimated survival probability curve for patients with hemoglobin A1c levels ≥7.0% according to the antidiabetic treatment (metformin use or metformin nonuse). The median survival time was 273 days (95% confidence interval [CI], 128.2 to 359.8) in the metformin use group and 145 days (95% CI, 39.5 to 256.3) in the metformin nonuse group (p=0.058).